PsychoactiveMap

Phase 4 psychedelic research trials

Data as of 31 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.

Phase 4 is a registry phase value. Studies of an intervention that is already approved for some use, run to learn more about its use in practice. A phase describes how a study is designed, not what it found.

Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.

At a glance

Which substances

Counts per substance hub. Ketamine is limited to studies classified as psychiatric research, and records about disease-modifying therapy that match the abbreviation DMT are removed.

Substance hubStudies
Ketamine67

By registry status

StatusStudiesShare
Recruiting913%
Not yet recruiting23%
Enrolling by invitation11%
Active, not recruiting34%
Completed3045%
Terminated69%
Suspended11%
Withdrawn34%
Status not reported1218%

Countries

Country is taken from the study's linked research site. 6 of 67 records have no country on file. The top 10 countries are shown.

CountryStudiesShare
United States3349%
Canada69%
Australia34%
China34%
Türkiye34%
Brazil23%
Germany23%
Egypt23%
United Kingdom23%
Israel23%

Registry-listed start years

Start yearStudies
2024 and later10
2020 to 202323
2015 to 201918
2010 to 201411
Before 20105

Study design

Topics named in study titles

A keyword match on registered titles, so one study can appear under more than one topic and a study can be missed. It describes what titles mention, nothing more.

TopicStudies
Depression and mood40
Suicidal thoughts11
Pain and headache2
Trauma and PTSD1
Anxiety1
Other substance use1
Cancer and end of life1
Healthy volunteers1

Latest registry-listed start dates

The 25 studies with the latest start dates, newest first. Dates may be estimated, including future dates; a listed date does not confirm that a study started. The order is not a ranking. Each ID links to its own ClinicalTrials.gov record.

Registry IDTitle as registeredStatusPhaseCountryRegistry dates
NCT07680140Biomarker-Guided Antidepressant SelectionRecruitingPhase 4United StatesSource start: 2026-08-10 (actual)
Saved start 2026-07-01 differs from reported 2026-08-10; the saved day is not established by this observation.
Source date details

Start: 2026-08-10 (precision: day; source type: ACTUAL; actual)

Primary completion: 2028-09 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2028-12 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-09-23 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07139106Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal ThoughtsNot yet recruitingPhase 4United StatesSource start: 2026-10-01 (estimated)
Saved start 2026-02-01 differs from reported 2026-10-01; the saved day is not established by this observation.
Source date details

Start: 2026-10-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2028-10-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2028-10-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.160Z; registry revision: 2026-08-03 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07369102Esketamine With or Without Integration Therapy for Treatment-Resistant DepressionRecruitingPhase 4Puerto RicoSource start: 2026-02-01 (estimated)
Source date details

Start: 2026-02-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2026-12-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2026-12-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.483Z; registry revision: 2026-01-27 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07120477Esketamine Versus Crisis Response Planning Versus Optimized Treatment as Usual for Suicide Prevention: A Pragmatic Controlled Trial in Two Brazilian CitiesRecruitingPhase 4BrazilSource start: 2026-06-01 (actual)
Saved start 2026-01-01 differs from reported 2026-06-01; the saved day is not established by this observation.
Source date details

Start: 2026-06-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2028-12 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2029-12 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.160Z; registry revision: 2026-09-16 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06968624Ketamine for Postherpetic Neuralgia With DepressionNot yet recruitingPhase 4Not reportedSource start: 2025-06-15 (estimated)
Source date details

Start: 2025-06-15 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2026-04-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2026-06-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.089Z; registry revision: 2025-06-03 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07053345A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant DepressionCompletedPhase 4South KoreaSource start: 2025-06-09 (actual)
Source date details

Start: 2025-06-09 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-07-13 (precision: day; source type: ACTUAL; actual)

Study completion: 2026-07-13 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:18.089Z; registry revision: 2026-08-03 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06414356The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSDRecruitingPhase 4United StatesSource start: 2024-10-02 (actual)
Source date details

Start: 2024-10-02 (precision: day; source type: ACTUAL; actual)

Primary completion: 2025-04 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2027-05 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:17.400Z; registry revision: 2025-02-25 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06278779Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant DepressionRecruitingPhase 4AustraliaSource start: 2024-06-03 (actual)
Source date details

Start: 2024-06-03 (precision: day; source type: ACTUAL; actual)

Primary completion: 2027-04 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2027-04 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:17.349Z; registry revision: 2026-05-29 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06077487Ketamine-assisted Therapy for Advanced GI CancerTerminatedPhase 4United StatesSource start: 2024-05-17 (actual)
Source date details

Start: 2024-05-17 (precision: day; source type: ACTUAL; actual)

Primary completion: 2025-01-31 (precision: day; source type: ACTUAL; actual)

Study completion: 2025-01-31 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:17.019Z; registry revision: 2025-05-21 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06213324Neural Circuit Effects of Ketamine in DepressionRecruitingPhase 4United StatesSource start: 2024-01-31 (actual)
Source date details

Start: 2024-01-31 (precision: day; source type: ACTUAL; actual)

Primary completion: 2028-03-30 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2028-04-30 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:17.349Z; registry revision: 2025-07-03 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06103760Positioning of Esketamine Treatment in the Real-world Management of DepressionRecruitingPhase 4AustraliaSource start: 2023-10-31 (actual)
Source date details

Start: 2023-10-31 (precision: day; source type: ACTUAL; actual)

Primary completion: 2027-12-15 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2028-08-15 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:17.019Z; registry revision: 2026-08-12 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06060210Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt InsertionCompletedPhase 4EgyptSource start: 2023-10-29 (actual)
Source date details

Start: 2023-10-29 (precision: day; source type: ACTUAL; actual)

Primary completion: 2025-09-01 (precision: day; source type: ACTUAL; actual)

Study completion: 2025-11-01 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:17.019Z; registry revision: 2026-01-08 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05554627VA Aripiprazole vs Esketamine for Treatment Resistant DepressionWithdrawnPhase 4United StatesSource start: 2023-10-27 (actual)
Source date details

Start: 2023-10-27 (precision: day; source type: ACTUAL; actual)

Primary completion: 2023-10-27 (precision: day; source type: ACTUAL; actual)

Study completion: 2023-10-27 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.599Z; registry revision: 2024-01-05 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06034821Comparative Effectiveness of ECT vs. KETAMINE Over the LifespanEnrolling by invitationPhase 4United States, CanadaSource start: 2023-10-01 (actual)
Source date details

Start: 2023-10-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2030-10-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2030-12-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:17.019Z; registry revision: 2025-12-15 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05698394Effect of Low-dose Esketamine on Maternal Depression at 3 Years After ChildbirthActive, not recruitingPhase 4ChinaSource start: 2023-09-09 (actual)
Source date details

Start: 2023-09-09 (precision: day; source type: ACTUAL; actual)

Primary completion: 2025-10 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2025-11 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:16.639Z; registry revision: 2024-12-05 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05997134Three Regimens of Ketamine Infusion in Complex Regional Pain SyndromeStatus not reportedPhase 4EgyptSource start: 2023-08-30 (actual)
Source date details

Start: 2023-08-30 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-09-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2024-09-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:16.980Z; registry revision: 2023-08-31 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05506462An EEG Study of Intravenous Ketamine for Major Depression DisorderStatus not reportedPhase 4Not reportedSource start: 2023-01 (estimated)
Saved start 2023-01-01 differs from reported 2023-01; the saved day is not established by this observation.
Source date details

Start: 2023-01 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2024-01 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2024-02 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:16.599Z; registry revision: 2022-08-22 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05615948Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for DepressionCompletedPhase 4United StatesSource start: 2022-12-06 (actual)
Source date details

Start: 2022-12-06 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-05-17 (precision: day; source type: ACTUAL; actual)

Study completion: 2024-05-17 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.599Z; registry revision: 2026-04-21 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05655754Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECTCompletedPhase 4AustriaSource start: 2022-11-01 (actual)
Source date details

Start: 2022-11-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-03-31 (precision: day; source type: ACTUAL; actual)

Study completion: 2026-03-31 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.599Z; registry revision: 2026-10-07 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05450432Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With DepressionRecruitingPhase 4United StatesSource start: 2022-10-13 (actual)
Source date details

Start: 2022-10-13 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-06-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2026-06-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:16.239Z; registry revision: 2025-12-12 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05487885Anhedonia, Development, and Emotions: Phenotyping and TherapeuticsCompletedPhase 4United StatesSource start: 2022-07-22 (actual)
Source date details

Start: 2022-07-22 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-12-19 (precision: day; source type: ACTUAL; actual)

Study completion: 2025-06-01 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.599Z; registry revision: 2026-03-17 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05950711Ketamine-Assisted Mindfulness-Based Cognitive Therapy for Depression: A Pilot StudyActive, not recruitingPhase 4United StatesSource start: 2022-03-30 (actual)
Source date details

Start: 2022-03-30 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-11-30 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2026-11-30 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:16.980Z; registry revision: 2025-08-11 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05045378Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant DepressionCompletedPhase 4TaiwanSource start: 2022-03-15 (actual)
Source date details

Start: 2022-03-15 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-11-30 (precision: day; source type: ACTUAL; actual)

Study completion: 2024-11-30 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.858Z; registry revision: 2025-09-05 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05026203Effectiveness of Ketamine Treatment for Three Consecutive Days in DepressionCompletedPhase 4ThailandSource start: 2021-09-01 (actual)
Source date details

Start: 2021-09-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2022-07-31 (precision: day; source type: ACTUAL; actual)

Study completion: 2023-11-30 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.858Z; registry revision: 2024-03-15 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT04829318A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray TreatmentCompletedPhase 4Taiwan, Türkiye, Poland, Czechia, Germany, Greece, Finland, South Korea, Bulgaria, Hungary, Argentina, South Africa, Malaysia, BelgiumSource start: 2021-04-26 (actual)
Source date details

Start: 2021-04-26 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-07-22 (precision: day; source type: ACTUAL; actual)

Study completion: 2024-07-22 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.827Z; registry revision: 2025-09-18 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Other substance hubs

Psilocybin | MDMA | LSD | DMT | 5-MeO-DMT | Ayahuasca | Ketamine | Ibogaine

Registry status hubs

Recruiting | Not yet recruiting | Active, not recruiting | Enrolling by invitation | Completed | Terminated | Suspended | Withdrawn

Phase hubs

Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase not applicable

All trial hubs | Learn | Disclaimer